FDA Announces Public Advisory Committee Meeting on Galleri Test for Breast Cancer Detection

Summary

The FDA is hosting a public meeting of the Molecular and Clinical Genetics Panel to discuss the Galleri test, a new breast cancer detection tool, and is seeking public comments on its establishment as a public docket.